Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-002046
Filing Date
2018-01-25
Accepted
2018-01-25 20:12:00
Documents
1
Period of Report
2018-01-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11620
  Complete submission text file 0000899243-18-002046.txt   13293
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WAVE LIFE SCIENCES LTD. 733 CONCORD AVE CAMBRIDGE MA 02138
Business Address
Vargeese Chandra (Reporting) CIK: 0001657675 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37627 | Film No.: 18549659